Captrust Financial Advisors Sells 128,335 Shares of CVS Health Co. (NYSE:CVS)

Captrust Financial Advisors trimmed its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 31.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 274,011 shares of the pharmacy operator's stock after selling 128,335 shares during the quarter. Captrust Financial Advisors' holdings in CVS Health were worth $12,300,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Ridgewood Investments LLC lifted its position in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after acquiring an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health during the 4th quarter worth about $28,000. Hopwood Financial Services Inc. bought a new stake in CVS Health during the 4th quarter valued at approximately $29,000. Financial Perspectives Inc grew its holdings in CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. lifted its holdings in shares of CVS Health by 112.1% during the fourth quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after buying an additional 437 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CVS shares. Leerink Partnrs raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 12th. Argus set a $77.00 price objective on shares of CVS Health in a research report on Tuesday, February 18th. Truist Financial lifted their target price on CVS Health from $76.00 to $82.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Piper Sandler upped their price target on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Finally, Evercore ISI lifted their price objective on CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $74.81.

CVS Health Price Performance

CVS traded down $0.87 during trading on Friday, hitting $66.98. The company's stock had a trading volume of 6,356,260 shares, compared to its average volume of 11,412,073. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $84.45 billion, a price-to-earnings ratio of 18.30, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The firm's 50 day moving average price is $66.96 and its two-hundred day moving average price is $59.03. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The firm's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.31 EPS. Sell-side analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.97%. CVS Health's payout ratio is 63.48%.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney bought 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.